Raymond James Financial Inc Xencor Inc Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Xencor Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 16,729 shares of XNCR stock, worth $249,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,729
Previous 21,493
22.17%
Holding current value
$249,763
Previous $168,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XNCR
# of Institutions
220Shares Held
81.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$166 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.7MShares$159 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.1MShares$106 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY6.22MShares$92.9 Million0.98% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$91.7 Million5.41% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $891M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...